Compare Aurora Cannabis Inc (ACB) vs Abrdn Physical Platinum Shares ETF (PPLT) Price & Performance

Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.

The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.

PPLT, the Aberdeen Physical Platinum Shares ETF, trades at $14.83, up 0.75% on the day, amid a bearish technical outlook with moving averages signaling sell pressure. The fund recently executed a 1-for-10 stock split effective May 18, 2026, adjusting share count without altering the underlying asset value. Key financial ratios are unavailable, as the ETF holds physical platinum, not generating traditional corporate earnings or sales.

The outlook for PPLT hinges on platinum price trends, which face headwinds from weaker industrial demand and competition from gold. Recent news highlights platinum's underperformance versus other precious metals, suggesting cautious sentiment. Risks include commodity volatility and economic cycles, while potential upside relies on a sustained rally in platinum markets.